An ongoing clinical trial called "BREAKWATER" is showing great promise for metastatic colon cancer patients with a particular ...

Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

Recent advances have resulted in highly effective "tissue-agnostic" drugs that treat cancers based on their molecular markers ...